Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Law and the Biosciences|December 26, 2022
Mifepristone, preemption, and public health federalismPatricia J Zettler, Annamarie Beckmeyer, Beatrice L Brown, et al.
BMJ Medicine|March 20, 2023
Evidence at time of regulatory approval and cost of new antibiotics in 2016-19: cohort study of FDA approved drugsMayookha Mitra-Majumdar, John H Powers, Beatrice L Brown, et al.
Journal of Health Politics, Policy and Law|July 22, 2022
Trends in the Quality of Evidence Supporting FDA Drug Approvals: Results from a Literature ReviewBeatrice L Brown, Mayookha Mitra-Majumdar, Krysten Joyce, et al.
Health Affairs (Project Hope)|November 19, 2020
An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19Aaron S Kesselheim, Jonathan J Darrow, Martin Kulldorff, et al.
Drug Safety|February 19, 2022
New Drug Postmarketing Requirements and Commitments in the US: A Systematic Review of the EvidenceOsman Moneer, Beatrice L Brown, Jerry Avorn, et al.
JAMA Network Open|May 17, 2022
Analysis of Supportive Evidence for US Food and Drug Administration Approvals of Novel Drugs in 2020Mayookha Mitra-Majumdar, Simon J Gunter, Aaron S Kesselheim, et al.
Pageof 1